Sales Growth YoY (Last Twelve Months): MoonLake Corp (MLTX)

Graphic logo of MoonLake Immunotherapeutics (MLTX)

Geopolitical instability and sanctions seriously hinder the conduct of global trials for new drugs from MoonLake Immunotherapeutics. MoonLake Immunotherapeutics minimizes risks by utilizing an asset-light model and outsourcing nanobody production to external contractors. Verified logistics channels ensure the delivery of samples to research centers. The LTM sales growth YoY reflects the business's resilience, where 0.00 represents the latest value of the metric.

Sales Growth YoY (Last Twelve Months): MoonLake Pharma (MLTX) for 02/11/2024 - 11/18/2026

Summary analytical data breakdowns for MoonLake Immunotherapeutics AG (MLTX)

- market value and analyst target forecast:
- company stock exchange capitalization indicators:
Analysis of all company metrics:MoonLake Immunotherapeutics
Mass-produced product of MoonLake

Revenue dynamics reflect business scaling rates by comparing current income with the previous year's figures. Analyzing year-over-year revenue changes using the TTM method allows for the identification of the actual speed of commercial growth while excluding seasonal fluctuations. This metric measures the efficiency of asset monetization, signaling either an expansion or stagnation phase. For MoonLake Immunotherapeutics (MLTX), this indicator will serve as key confirmation of the market penetration of their unique nanobodies in inflammation therapy.

Competitors of MoonLake Immunotherapeutics (MLTX)

Ascendis (ASND) - Trailing Twelve Months Revenue Growth|MDGL - Sales Growth YoY (Last Twelve Months)|CORT: Sales Growth YoY (Last Twelve Months)|RYTM: Sales Growth YoY (TTM)|AKRO - Annual Revenue Growth (Last Twelve Months)|Sales Growth YoY (Last Twelve Months) Metsera Therapeutics|Crinetics Corp (CRNX) - Annual Revenue Growth (Last Twelve Months)|Sales Growth YoY (Last Twelve Months) newamsterdampharma.com (NAMS)|Revenue Growth YoY (Last 12 Months) soleno.life SLNO|Sales Growth YoY (TTM) FOLD (amicusrx.com)|Annual Revenue Growth (Last Twelve Months) 89bio (ETNB)|Agios - Sales Growth YoY (TTM)|Structure Corp - Revenue Change YoY (Last 12 Months)|mimedx.com (MDXG) - Sales Growth YoY (Last Twelve Months)|Trailing Twelve Months Sales Growth RZLT (rezolutebio.com)|LXRX (Lexicon Pharmaceuticals Inc) - Sales Growth YoY (TTM)|Sales Growth YoY (Last Twelve Months) MBX|Sales Growth YoY (Last Twelve Months) Altimmune Pharma (ALT)|Sales Growth YoY (Last Twelve Months) AARD (Aardvark Therapeutics Corp)|Sales Growth YoY (TTM) SGMT (Sagimet Biosciences, Inc.)|BioAge (BIOA) - Trailing Twelve Months Revenue Growth|BMEA: Revenue Growth YoY (Last 12 Months)|Revenue Dynamics YoY (Last Twelve Months) QNCX (Quince Therapeutics Inc)|GUTS (Fractyl) - Revenue Growth YoY (Last 12 Months)|vTv Therapeutics, Inc. - Revenue Dynamics YoY (Last Twelve Months)|Sales Growth YoY (Last Twelve Months) Agape ATP Corp.|Revenue Growth YoY (Last 12 Months) Pluri (PLUR)|Sales Growth YoY (TTM) SYBX|Annual Revenue Growth (Last Twelve Months) Lipocine Inc|Sales Growth YoY (Last Twelve Months) Matinas BioPharma Holdings MTNB|Annual Revenue Growth (Last Twelve Months) Spruce Biosciences (SPRB)|GLTO: Revenue Growth YoY (Last 12 Months)|Trailing Twelve Months Sales Growth CTCX|LUMO (Lumos Pharma) - Revenue Growth YoY (Last 12 Months)|Sales Growth YoY (Last 12 Months) ONVO|RDUS (Radius Pharmaceuticals) - Sales Growth YoY (TTM)